FFFrancesca Falconi-Agapito

Francesca Falconi-Agapito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Francesca Falconi-Agapito has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multi-model approach to understand and predict past and future dengue epidemic dynamics

    by Cathal Mills, Francesca Falconi-Agapito, Jean-Paul Carrera, Cesar Munayco, Moritz U.G. Kraemer, Christl A. Donnelly

    Understanding the past, current and future dynamics of dengue epidemics is challenging yet increasingly important for global public health. Using data from northern Peru across 2010–2021, we introduce a multi-model approach that integrates new and existing techniques for understanding and predicting dengue epidemics. Using wavelet analyses, we unveil spatio-temporal patterns and estimate space-varying epidemic drivers across shorter and longer dengue cycles, while our Bayesian hierarchical model allows us to quantify the timing, structure and intensity of such climatic influences. For forecasting, as a single model is generally suboptimal, we introduce trained and untrained probabilistic ensembles. In settings that mirror real-world implementations, we develop climate-informed and covariate-free deep learning forecasting models involving foundational time series, temporal convolutional networks and conformal inference. We complement modern techniques with statistically principled training, assessment and benchmarking of ensembles, alongside interpretable metrics for outbreak detection to disseminate outputs with communities and public health authorities. Our ensembles generally outperformed individual models across space and time. Looking forward, whether the public health objective is to learn from the past and/or to predict future dengue epidemic dynamics, our multi-model approach can be used to inform the decision-making and planning of public health authorities.


  • Open Access

    A new genetic variant of dengue serotype 2 virus circulating in the Peruvian Amazon

    by Francesca Falconi-Agapito, Philippe Selhorst, Xiomara Merino, Fiorella Torres, Johan Michiels, Connie Fernandez, Michael Talledo, Kevin K. Ariën


  • Reliable Serological Diagnostic Tests for Arboviruses: Feasible or Utopia?

    by Karen Kerkhof, Francesca Falconi-Agapito, Marjan Van Esbroeck, Michael Talledo, Kevin K. Ariën


  • Naturally Occurring β-Nicotinamide Adenine Dinucleotide–IndependentAvibacterium paragallinarumIsolate in Peru

    by Francesca Falconi-Agapito, Luis E. Saravia, Aldo Flores-Pérez, Manolo Fernández-Díaz

    The β-nicotinamide adenine dinucleotide (NAD) requirement has been considered to be essential for the isolation of the causal agent of infectious coryza, Avibacterium paragallinarum. Nevertheless, NAD-independent reports from South Africa and Mexico dismissed this paradigm. It is now accepted that both NAD-dependent and NAD-independent agents are able to cause infectious coryza and thus belong to the species A. paragallinarum. Here, we report for the first time in Peru a NAD-independent isolate from broiler chickens with typical signs of infectious coryza that have received a trivalent inactivated vaccine against infectious coryza. The isolate was identified based on its morphology, biochemical and serologic tests, and PCR results. Partial 16S rRNA gene sequence analysis confirmed the isolate as A. paragallinarum. There have been no cases of NAD-independent A. paragallinarum isolates reported in South America. Increasing reports around the world highlight not only the need to reconsider the in vitro nutritional requirements of this species for its correct isolation but also the cross-protection conferred by commercial infectious coryza vaccines against NAD-independent isolates.